CARLSMED, INC. (CARL) Financial Statements
CARLSMED, INC. (CARL) reported trailing twelve-month revenue of $63.3M (up 65.4% year on year) and net income of -$36.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$35.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CARLCARLSMED, INC.Follow CARL — free
—
Price chart with a free account
- Market cap
- 396.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Revenue | 27.2 | 50.5 | 63.3 | |
| Gross profit | 20.0 | 38.0 | 48.5 | |
| Research & development | 14.3 | 17.0 | 20.9 | |
| Operating income | -24.1 | -30.6 | -38.7 | |
| Pre-tax income | -24.3 | -29.6 | -36.3 | |
| Income tax | — | 0.0 | 0.0 | |
| Net income | -24.3 | -29.6 | -36.3 | |
| Diluted EPS ($) | -6.11 | -2.12 | -1.33 | |
| Diluted shares (mn) | 4.1 | 14.2 | — |
USD millions · SEC XBRL
CARLSMED, INC. — questions
- What is CARLSMED, INC.'s revenue?
- $63.3M over the twelve months to 2026-06-30, up 65.4% year on year, from its 10-Q and 10-K filings.
- What is CARLSMED, INC.'s net income?
- -$36.3M over the twelve months to 2026-06-30.
- What is CARLSMED, INC.'s free cash flow?
- -$35.7M over the twelve months to 2026-06-30.
- What are CARLSMED, INC.'s diluted earnings per share?
- $-1.33 over the twelve months to 2026-06-30.
Every figure on this page comes from CARLSMED, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.